Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Strategy Inc. (MSTR) vs 22nd Century Group Inc (XXII) Price & Performance

Strategy Inc.Trade
22nd Century Group IncTrade

Price performance (Past 24H)

Key statistics

Strategy Inc. vs 22nd Century Group Inc — how do they compare? Strategy Inc. trades at $154.68 (market cap $60.40B), while 22nd Century Group Inc trades at $0.84 (market cap $621.67K). The key difference: Strategy Inc. is far larger — about 97157.7× 22nd Century Group Inc's market cap, and Strategy Inc. is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Strategy Inc. for 112 Days and 22nd Century Group Inc for 32 Days on average.

MSTRXXII
Market Cap
$60.40B$621.67K
Volume
23,421,83045,625
Sector
TechnologyConsumer Staples
52-Week High
$320.29$483.00
52-Week Low
$82.31$0.80
Typical Hold Time
112 Days32 Days
Enterprise Value
$79.16B-$3.69M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Strategy Inc.

MSTR stock trades at $155.91, up 1.66% on the day, with a bullish technical signal from moving averages but mixed oscillators. The company reported a net loss of $3.85 billion in 2025 on $477.23 million in revenue, with a negative net income margin of -806.35%. Recent news highlights Bitcoin's price surge and Citigroup raising its price target to $240, though the stock has shown volatility around Bitcoin price movements.

The outlook is polarized: analyst consensus is bullish with a $253.36 price target, but fundamental risks are high due to persistent losses, negative cash flow from operations, and heavy debt. Investment opportunity hinges on Bitcoin's performance, while risks include earnings misses and financial instability.

22nd Century Group Inc

22nd Century Group (XXII) trades at $0.89, down 0.94% today, with a bearish technical signal despite oversold RSI readings. The company shows severe financial stress with negative gross margins of -54.6% and net income margin of -76.01%, though valuation metrics appear low with P/S of 0.09 and P/B of 0.03. Recent news highlights regulatory progress in nicotine reduction initiatives and expanded retail distribution for VLN products.

While analyst consensus remains bullish with 75% buy ratings and a $1,240 price target, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock presents high-risk speculation on regulatory adoption of reduced-nicotine standards, requiring careful risk assessment given the company's ongoing losses and cash burn.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MSTR
57% Buy43% Sell
Avg holding period · 112 Days
XXII
100% Buy0% Sell
Avg holding period · 32 Days

Top news

Latest headlines on both assets

About Strategy Inc.

MicroStrategy Inc is a provider of enterprise analytics and mobility software. It offers MicroStrategy Analytics platform that delivers reports and dashboards and enables users to conduct ad hoc analysis and share insights through mobile devices or the Web

Read more on MSTR →

About 22nd Century Group Inc

22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.

Read more on XXII →